首页> 外文OA文献 >Peroxisome proliferator-activated receptor gamma (PPAR-γ) and its effects on the Cardiovascular system
【2h】

Peroxisome proliferator-activated receptor gamma (PPAR-γ) and its effects on the Cardiovascular system

机译:过氧化物酶体增殖物激活受体γ(PPAR-γ)及其对心血管系统的影响

摘要

Cardiovascular disease is one of the leading causes of death in the United States. Studying the pathogenesis of cardiovascular disease is, therefore, essential for the possible alleviation of such cases. Further knowledge could lead to more effective drug treatment. Peroxisome proliferator-activated receptor gamma (PPAR-γ) is a nuclear receptor found in vascular-associated cells such as endothelial cells, macrophages, and vascular smooth muscle cells. Its role in cardiovascular pathogenesis has garnered great interest in recent years. Nonsense mutation studies show that PPAR-γ is essential for normal vascular function. Some studies even suggest that increased activation of PPAR-γ improves vascular function in dysfunctional states such as hypertension. However, some studies question PPAR-γ’s role and even suggest that it may play a negative role in some cardiovascular diseases, such as atherosclerosis. The overall evidence currently suggests that PPAR-γ is a potential target for agonists in combating cardiovascular disease, yet it is still unclear whether or not PPAR-γ has potentially negative effects on cardiovascular health when it is up-regulated.
机译:在美国,心血管疾病是主要的死亡原因之一。因此,研究心血管疾病的发病机制对于缓解此类病例至关重要。进一步的知识可能会导致更有效的药物治疗。过氧化物酶体增殖物激活受体γ(PPAR-γ)是在血管相关细胞(如内皮细胞,巨噬细胞和血管平滑肌细胞)中发现的核受体。近年来,其在心血管发病机理中的作用引起了极大的兴趣。无意义的突变研究表明,PPAR-γ对于正常的血管功能至关重要。一些研究甚至表明,PPAR-γ活化的增强可改善功能障碍状态(例如高血压)中的血管功能。但是,一些研究质疑PPAR-γ的作用,甚至暗示它可能在某些心血管疾病(例如动脉粥样硬化)中起负面作用。目前的整体证据表明,PPAR-γ是激动剂对抗心血管疾病的潜在靶标,但尚不清楚PPAR-γ上调时是否会对心血管健康产生潜在的负面影响。

著录项

  • 作者

    Duffy Kevin;

  • 作者单位
  • 年度 2013
  • 总页数
  • 原文格式 PDF
  • 正文语种
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号